Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs

References

• Lenehan P, Bellis M A, McVeigh J. A study of anabolic steroid use in the North West of England. J Perform Enhancing Drugs 1996; 1: 57–70
   Google Scholar
• Parkinson A B, Evans N A. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 2006; 38: 644–651
   PubMed Web of Science ®Google Scholar
• Peters R, Copeland J, Dillon P, Beel A. Patterns and correlates of anabolic–androgenic steroid use. National Drug and Alcohol Research Centre, University of New South Wales, SydneyAustralia 1997
   Google Scholar
• Dunn F. Two cases of biceps injury in bodybuilders with initially misleading presentation. Emerg Med J 2002; 19: 461–462
   PubMed Web of Science ®Google Scholar
• Pope H GJ, Brower K J. Anabolic–androgenic steroids. Textbook of substance abuse treatment, M Galanter, H D Kleber. American Psychiatric Publishing Inc, Washington, DC 2004; 257–264
   Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey: prevalence of HIV, HCV and injecting and sexual behaviour among IDU at needle and syringe programs. National Data Report 2000–2004, 2005. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney 2005
   Google Scholar
• Rich J D, Foisie C K, Towe C W, Dickinson B P, McKenzie M, Salas C M. Needle exchange program participation by anabolic steroid injectors, United States 1998. Drug Alcohol Depend 1999; 56: 157–160
   PubMed Web of Science ®Google Scholar
• Aitken C, Delalande C, Stanton K. Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic–androgenic steroid injectors in Victoria, Australia. Drug Alcohol Depend 2002; 65: 303–308
   PubMed Web of Science ®Google Scholar
• Crampin A C, Lamagni T L, Hope V D, et al. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiol Infect 1998; 121: 381–386
   PubMed Web of Science ®Google Scholar
• O'Sullivan A J, Kennedy M C, Casey J H, Day R O, Corrigan B, Wodak A. Anabolic–androgenic steroids: medical assessment of past, present and potential users. Med J Aust 2000; 173: 323–327
   PubMed Web of Science ®Google Scholar
• Day C A, Topp L, Iversen J, Maher L. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey. Drug Alcohol Rev 2008; 27(5)559–561
   PubMed Web of Science ®Google Scholar
• Aitken C, Delalande C. Are people who inject steroids risking blood-borne virus infection?. Vict Infect Dis Bull 1999; 2: 54
   Google Scholar
• Bolding G, Sherr L, Maguire M, Elford J. HIV risk behaviours among gay men who use anabolic steroids. Addiction 1999; 94: 1829–1835
   PubMed Web of Science ®Google Scholar
• Midgley S, Heather N, Best D, Henderson D, McCarthy S, Daview J B. Risk behaviours for HIV and hepatitis infection among anabolic–androgenic steroid users. AIDS Care 2000; 12: 163–170
   PubMed Web of Science ®Google Scholar
• Bolding G, Sherr L, Elford J. Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction 2002; 97: 195–203
   PubMed Web of Science ®Google Scholar
• Melia P, Pipe A, Greenberg L. The use of anabolic–androgenic steroids by Canadian students. Clin J Sports Med 1996; 6: 9–14
   PubMed Web of Science ®Google Scholar
• Best D, Midgley S. Assessing HIV risk behaviour among users of anabolic steroids in Newcastle upon Tyne. J Perform Enhancing Drugs 1998; 2: 20–23
   Google Scholar
• Rich J D, Dickinson B P, Flanigan T P, Valone S E. Abscess related to anabolic–androgenic steroid injection. Med Sci Sports Exercise 1999; 31: 207–209
   PubMed Web of Science ®Google Scholar
• Morrison C L. Anabolic steroid users identified by needle and syringe exchange contact. Drug Alcohol Depend 1994; 36: 153–155
   PubMed Web of Science ®Google Scholar
• Dickinson B P, Mylonakis E, Strong L, Rich J D. Potential infections related to anabolic steroid injection in young adolescents. Pediatrics 1999; 103: 694
   PubMed Web of Science ®Google Scholar
• Rich J D, Dickinson B P, Fellar A, Pugatch D, Mylonakis E. The infectious complications of anabolic–androgenic steroid injection. Int J Sports Med 1999; 20: 563–566
   PubMed Web of Science ®Google Scholar
• Rich J D, Dickinson B P, Merriman N A, Flanigan T P. Hepatitis C virus infection related to anabolic–androgenic steroid injection in a recreational weight lifter. Am J Gastroenterol 1998; 93: 1598
   PubMed Web of Science ®Google Scholar
• Australian Olympic Committee, Submission. Substance abuse in Australian communities. Parliamentary Inquiry. 2000, Standing Committee on Family and Community Affairs. Commonwealth of Australia. http://www.aph.gov.au/House/committee/fca/subabuse/sub55.pdf (accessed 22 September 2008)
   Google Scholar
• Dollman B, Henry-Edwards S. Performance and image enhancing drugs. Public Health Bulletin, South Australia 2005; 2: 4–7
   Google Scholar
• Peters R, Copeland J, Dillon P. Anabolic–androgenic steroids: user characteristics, motivations and deterrents. Psychol Addict Behav 1999; 13: 232–242
   Web of Science ®Google Scholar
• Biernacki P, Waldorf D. Snowball sampling: problems, techniques and chain referral sampling. Sociol Meth Res 1981; 10: 141–163
   Web of Science ®Google Scholar
• Copeland J, Peters R, Dillon P. Anabolic–androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend 2000; 60: 91–96
   PubMed Web of Science ®Google Scholar
• Dillon P, Copeland J, Peters R. Exploring the relationship between male homo/bi-sexuality, body image and steroid use. Culture Health Sexuality 1999; 1: 317–327
   Google Scholar
• Handelsman D J, Gupta L. Prevalence and risk factors for anabolic–androgenic steroid abuse in Australian high school students. Int J Androl 1997; 20: 159–164
   PubMed Web of Science ®Google Scholar
• Kindlundh A MS, Hagekull B, Isacson D. Adolescent use of anabolic–androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health 2001; 11: 322–328
   PubMed Web of Science ®Google Scholar
• Miller K E, Barnes G M, Sabo D F, Mellnick M J, Farrell M P. Androgenic–anabolic steroid use and other adolescent problem behaviours: rethinking the male athlete assumption. Sociol Perspect 2002; 45: 467–489
   Web of Science ®Google Scholar
• Aitken C, Delalande C. A public health initiative for steroid users in Victoria. Aust J Public Health 2002; 8: 21–23
   Google Scholar